AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

The Regulatory Landscape of Laboratory Developed Testing Procedures

Joint Policy Briefing


In this four part video, experts from the American Association for Clinical Chemistry (AACC), the American College of Medical Genetics and Genomics (ACMG), the Association for Molecular Pathology (AMP), and the Association of Pathology Chairs (APC) host a joint presentation on The Regulatory Landscape of Laboratory Developed Testing Procedures: How we got here, why it’s important, where we’re going, and how you can get involved.

This series covers the current regulatory process, proposed changes, and the potential impact such changes may have on the clinical laboratory’s ability to continue performing safe, life-saving laboratory developed testing procedures. All four modules of the presentation are posted individually below.

Module 1: Background on LDTs/LDPs


Module 2: The Importance of LDTs to Clinical Care


Module 3: Past and Current LDT Policy Proposals


Module 4: Advocating for LDTs